COMMUNIQUÉS West-GlobeNewswire

Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications

20/12/2017 - 20:00

PITTSBURGH, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and [...]

Procter & Gamble Present Donation to American College of Prosthodontists Education Foundation

20/12/2017 - 18:17

Chicago, Dec. 20, 2017 (GLOBE NEWSWIRE) -- P&G Crest Oral-B continue their legacy of supporting the dental specialty of prosthodontics by donating a total of $80,000 in 2017 to the American College of [...]

CORRECTION - Achillion Pharmaceuticals, Inc.

20/12/2017 - 18:12

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- In the news release issued earlier today by Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), please be advised the headline should read "Achillion Initiates Phase I [...]

Adherium Highlights Milestones Achieved in Advance of 2018

20/12/2017 - 18:03

SAN MATEO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today highlighted milestones achieved in advance of 2018. “As we [...]

Sensorion to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018

20/12/2017 - 18:00

MONTPELLIER, France, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible), a biotech company pioneering novel treatments of inner ear diseases, today announced that its senior management [...]

CyberFuels, Inc. Completes Agreement with Hightowers Petroleum Company for Supply Management and Logistic Services for United States and Canada

20/12/2017 - 17:05

PALM BEACH, Fla., Dec. 20, 2017 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ECSL) is pleased to announce that its subsidiary CyberFuels, Inc. has completed an agreement with Hightowers Petroleum Company for fuel [...]

Tivity Health to Present at the 36th Annual J.P. Morgan Healthcare Conference

20/12/2017 - 17:00

NASHVILLE, Tenn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) will present at the 36 th Annual J.P. Morgan Healthcare Conference to be held January 8 ‑ 11, 2018, in San Francisco. Donato [...]

Gunnison Valley Health Significantly Improves Revenue Cycle Time with ABILITY | EASE All-Payer

20/12/2017 - 16:00

MINNEAPOLIS, Dec. 20, 2017 (GLOBE NEWSWIRE) -- ABILITY Network today announced that Gunnison Valley Health has streamlined its revenue cycle complexity with the addition of ABILITY | EASE ® All-Payer. Gunnison Valley [...]

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

20/12/2017 - 16:00

BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test based on a protein [...]

Imaging3 appoints John Hollister as CEO

20/12/2017 - 15:30

BURBANK, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG) announced today that it has appointed John Hollister as chief executive officer and chairman of the board. Mr. Hollister brings over 25 [...]

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock

20/12/2017 - 15:11

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Hemispherx Successfully Completes Commercial Scale Demonstration Batch of Ampligen® at Contract Manufacturer

20/12/2017 - 15:00

NEW BRUNSWICK, N.J., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) said, its Contract Manufacturing Organization (CMO) for Ampligen® has completed a commercial scale demonstration/ [...]

BIOLIFE4D Helping Others to Give the Gift of Time this Holiday Season

20/12/2017 - 15:00

CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is taking indications of interest for [...]

Crown Bioscience International announces Agreement and Plan of Merger with JSR Corporation

20/12/2017 - 15:00

SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience International (“CrownBio”) (TWSE:ticker 6554) on December 19, 2017 has entered into the Agreement and Plan of Merger (the “Merger Agreement”) with JSR [...]

Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer

20/12/2017 - 14:50

MEDFORD, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the appointment of Neil A. Goldman, [...]

Abeona Therapeutics Enrolls First Patient in ABO-101 Phase 1/2 Clinical Trial for MPS IIIB

20/12/2017 - 14:45

NEW YORK and CLEVELAND, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel gene and cell therapies for life- [...]

BioDelivery Sciences Appoints Scott Plesha to President

20/12/2017 - 14:45

RALEIGH, N.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) announced the appointment of Scott Plesha, currently Senior Vice President of Sales and Marketing at BDSI, to the [...]

Marrone Bio Innovations and DISAGRO Sign Exclusive Distribution Agreement for REGALIA® Maxx Biofungicide in Central America

20/12/2017 - 14:30

DAVIS, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device

20/12/2017 - 14:30

REDWOOD CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced Conformité Européenne (CE) Marking [...]